A carregar...
TCR-based Immunotherapy for Hematologic Malignancies
Adoptive immunotherapy with engineered T cells is at the forefront of cancer treatment. T cells can be engineered to express T cell receptors (TCR) specific for tumor-associated antigens (TAAs) derived from intracellular or cell surface proteins. T cells engineered with TCRs (TCR-T) allow for target...
Na minha lista:
| Publicado no: | Cancer J |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6540815/ https://ncbi.nlm.nih.gov/pubmed/31135525 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/PPO.0000000000000378 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|